FDA Inspection 1235695 — OneBlood Inc
The FDA completed an inspection of OneBlood Inc on Apr 2, 2024 in Winter Haven, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 2, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Winter Haven, FL (United States)